Abstract-Increased cyclic stretch to the vessel wall, as observed in hypertension, leads to endothelial dysfunction through increased free radical production and reduced nitric oxide bioavailability. Genetic deletion of the adaptor protein p66 Shc protects mice against age-related and hyperglycemia-induced endothelial dysfunction, as well as atherosclerosis and stroke. Furthermore, p66 Shc mediates vascular dysfunction in hypertensive mice. However, the direct role of p66
H ypertension is an established risk factor for the development of cerebrovascular and cardiovascular disease [1] [2] [3] ; in patients with hypertension, each increase of 1 mm Hg in blood pressure corresponds to a 1% increase in stroke mortality. 4 Hypertension exerts its deleterious effects on the vessel wall mainly via mechanical forces such as shear stress and cyclic stretch. 5 Under physiological conditions, mechanical forces are crucial for the maintenance of vascular cell homeostasis 6 ; however, pathologically increased mechanical forces, as observed in hypertension, lead to adaptive changes in vascular cells that may cause endothelial dysfunction and vascular disease. 7 During the past years, several studies have demonstrated an increased production of reactive oxygen species (ROS) by endothelial cells exposed to pathological cyclic stretch. [8] [9] [10] An increased production of ROS perturbs the physiological redox balance, inducing oxidative stress resulting in inactivation of nitric oxide (NO). 11 This in turn leads to endothelial dysfunction, a key step in the pathophysiology of many cardiovascular diseases.
p66
Shc belongs to the mammalian Shc adaptor protein family, 13, 14 participates in ROS production, [15] [16] [17] [18] [19] and is involved in translation of oxidative stimuli into apoptosis. 20, 21 Genetic deletion of p66 Shc in mice was shown to improve endothelial function in different disease models. 15, 16, 18 In particular, p66 Shc mediates vascular dysfunction observed in angiotensin II-treated, hypertensive mice. 22 Nevertheless, the role of p66
Shc in mediating the deleterious effects of pathological cyclic stretch on the vasculature is not known.
Hypertension
August 2014
The present study was designed to characterize the role of p66
Shc in cyclic stretch-induced endothelial damage. In particular, we assessed whether p66
Shc mediates the increased superoxide anion (O 2 − ) production and the decreased NO bioavailability observed in endothelial cells exposed to pathological cyclic stretch. Finally, to assess the relevance of our findings in vivo, we explored whether p66
Shc activation is increased in isolated aortic endothelial cells of spontaneously hypertensive rats (SHR).
Materials and Methods
Detailed Materials and Methods are available in the online-only Data Supplement.
Cell Culture Experiments
For all in vitro experiments, primary human aortic endothelial cells (HAECs; Lonza) from passages 6 to 9 were used. Detailed Methods are provided in the online-only Data Supplement.
siRNA Transfection
Cells were transfected with predesigned small interfering RNA (siRNA) against p66 Shc using N-TER Nanoparticle siRNA Transfection System (Sigma-Aldrich) or by using Lipofectamine RNAiMAX Reagent (Invitrogen). Detailed Methods are provided in the online-only Data Supplement.
Application of Cyclic Stretch
Cyclic stretch to adhering cells on BioFlex culture plates (Flexcell International) was applied using the Flexcell FX-4000T system (Flexcell International). Detailed Methods are provided in the onlineonly Data Supplement.
Immunoblotting
Protein expression and activation were determined by immunoblot analysis. Cells were lysed in lysis buffer, and equal amounts of protein were separated by SDS-PAGE. Detailed Methods are provided in the online-only Data Supplement.
Measurement of O 2 − Production and NO Bioavailability
O 2 − production and NO bioavailability in intact cells or aortic tissue were determined using electron spin resonance spectroscopy. Detailed Methods are provided in the online-only Data Supplement.
NADPH Oxidase Activity Measurement
Determination of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation was performed using a commercially available kit (Abcam) and performed according to the manufacturer's recommendations.
Animal Experiments
Sixteen-week-old male SHR and male Wistar-Kyoto (WKY) rats were purchased from Janvier Laboratories. Study design and experimental protocols were approved by the Cantonal Veterinary Office of the Canton of Zurich. Detailed Methods are provided in the onlineonly Data Supplement.
Statistical Analysis
Data are presented as mean±SEM. Statistical analysis for comparison of 2 groups was performed using 2-tailed unpaired Student t test or Mann-Whitney test when appropriate. For comparison of >2 unmatched groups, 1-way ANOVA followed by the Bonferroni post hoc test or Kruskal-Wallis test followed by the Dunn post hoc test was performed when appropriate. A value of P<0.05 denoted a significant difference. Statistical analysis was performed using GraphPad Prism software 5.01.
Results

Cyclic Stretch Enhances p66
Shc Activation in a Stretch-and Time-Dependent Manner Exposure of HAECs to pathological cyclic stretch (8% and 15% stretch) for 6 hours resulted in a stretch-dependent increase in p66
Shc phosphorylation at Ser36 compared with static condition, whereas no change in p66
Shc activation was observed under physiological stretch (2%; Figure 1A ). In addition, the extent of p66
Shc activation was time-dependent as observed after exposure of HAECs to 1, 3, or 6 hours of pathological cyclic stretch ( Figure 1B ). All conditions did not change p66
Shc protein expression ( Figure 1A and 1B). To exclude potential cytotoxic effects of pathological cyclic stretch, a colorimetric assay for detection of lactate dehydrogenase release was performed. No cytotoxicity was observed when cells were exposed to pathological cyclic stretch compared with static condition (data not shown).
MAPK JNK1/2 Mediates Pathological StretchIncreased p66
Shc Activation
Immunoblot analysis revealed an enhanced activation of the mitogen-activated protein kinases (MAPKs) c-Jun N-terminal kinase (JNK) 1/2 ( Figure 2A) Shc activation ( Figure 2B ). In contrast, this was not observed when p38 or ERK1/2 was inhibited (data not shown). To assess whether p66
Shc activation in response to pathological cyclic stretch occurs upstream or downstream of JNK1/2, the effect of p66
Shc silencing on pathological stretch-increased JNK1/2 activation was assessed. Preincubation of HAECs with siRNA-specific targeting p66 To assess the effect of p66
Shc silencing or JNK1/2 inhibition on stretch-increased O 2 − production and stretch-reduced NO bioavailability, HAECs were transfected with siRNAspecific targeting p66
Shc or pretreated with SP600125 (1 µmol/L). Silencing of p66
Shc or JNK1/2 inhibition reduced stretch-increased O 2 − generation ( Figure 3A ) and resulted in an increased NO bioavailability under pathological stretch condition ( Figure 3C ). Furthermore, p66
Shc silencing reduced stretch-increased NADPH oxidase activity ( Figure 3B ). Previously, a role for p66
Shc in inhibiting endothelial NO synthase (eNOS)-dependent NO production was demonstrated. 23 Here, we investigated the potential effect of p66 Shc silencing on eNOS under pathological stretch condition.
Immunoblotting did not reveal any influence of p66 Shc silencing under stretch condition on both Ser1177 ( Figure 3D ) and Thr495 ( Figure 3E ) phosphorylation sites of eNOS or on eNOS protein expression ( Figure 3D and 3E).
Functional Integrin α 5 β 1 Inhibition Diminishes Both p66
Shc and JNK1/2 Activation Increased by Pathological Stretch
Integrins are known to translate extracellular mechanical stimuli into intracellular adaptations. 24 To address the role of integrin α 5 β 1 in pathological stretch-increased p66
Shc activation, its function was blocked using an anti-integrin α 5 β 1 antibody 25 (10 µg/mL) before pathological stretch exposure. Thereby, pathological stretch-increased p66
Shc activation was reduced ( Figure 4A ). In line with this, pathological stretch-increased JNK1/2 activation was decreased by functional integrin α 5 β 1 inhibition ( Figure 4B ).
p66 Shc Activation Is Elevated in the Endothelium of Hypertensive Rats
To test the physiological relevance of the data obtained in vitro, regulation of p66
Shc was studied in vivo by assessing its activation in aortic endothelial cells of SHR compared with normotensive WKY rats. Blood pressure monitoring showed elevated systolic blood pressures in SHR compared with WKY rats, whereas no difference in heart rate was observed (data not show). Immunoblot analysis revealed an increase in p66
Shc phosphorylation at Ser36 in aortic endothelial cells of SHR compared with WKY rats, without showing altered p66
Shc protein expression ( Figure 5A ). In addition, in aortic homogenates of SHR, we observed an increased O 2 − generation ( Figure 5B ) as well as a reduction in NO bioavailability ( Figure 5C ) compared with WKY.
Discussion
This study demonstrates for the first time that pathological cyclic stretch causes an increased endothelial O 2 − production and a reduced NO bioavailability through the activation of the adaptor protein p66
Shc downstream of integrin α 5 β 1 and JNK1/2 and upstream of the NADPH oxidase. Next, we confirm that p66
Shc activation is increased also in isolated aortic endothelial cells of SHR compared with WKY rats.
Vascular cells are constantly exposed to mechanical forces, such as shear stress and cyclic stretch. 5 The location of integrins between the extracellular matrix and intracellular cytoskeleton elements assigns them an important function as mechanotransducers. 26, 27 Integrins were shown to be crucial in translating pathologically increased mechanical stimuli into morphological and intracellular adaptations. 24, 28 In this study, we focused on investigating the role of α 5 β 1 integrin, which is known to be abundantly expressed in endothelial cells 29 and to adhere to fibronectin. 30 Functional blockade of integrin α 5 β 1 abolished pathological stretch-increased p66
Shc phosphorylation and JNK1/2 activation, demonstrating that integrin α 5 β 1 acts as a key mechanotransducer for the pathological endothelial adaptations observed in the present study ( Figure 6 ).
Pathways mediating extracellular signals to crucial endothelial proteins may involve protein kinase C 31 and the MAPKs JNK, p38, and ERK. 32 A role for protein kinase C 33 and 
MAPKs
34 in endothelial cell adaptations induced by pathological cyclic stretch has been reported previously. Furthermore, JNK is a known activator of p66
Shc after stimulation of endothelial cells with oxidized low-density lipoprotein. 35 Unlike protein kinase C βII, phosphorylation of JNK1/2, p38, and ERK1/2 was enhanced after exposure to pathological stretch. However, only inhibition of JNK1/2, and not inhibition of p38 or ERK1/2, blunted p66
Shc activation and O 2 − production and restored NO bioavailability after pathological stretch, thus indicating a pivotal role for JNK1/2 in these settings.
An increased level of endothelial ROS after pathological stretch exposure, as observed in our study, is in line with previous investigations. 8, 9 A balance between ROS production and degradation is essential to maintain 21 and the perturbation of this redox balance, by an increased ROS production and a decreased antioxidant capacity, induces oxidative stress resulting in endothelial dysfunction, 21 a common denominator to many cardiovascular diseases, such as hypertension. 36, 37 Previously, NADPH oxidase has been demonstrated to be a major source for pathological stretch-increased O 2 − generation. 8 Furthermore, NADPH oxidase was demonstrated to be a downstream target of p66 Shc , 35 thus NADPH oxidase may represent the source of stretch-increased O 2 − production downstream of p66 Shc . In the present study, we showed that silencing of p66
Shc prevents stretch-increased NADPH oxidase activity, suggesting that pathological stretch leads to an increase in p66 Shc activation, which in turn activates NADPH oxidase and as a consequence increases O 2 − generation. NO is a key mediator of endothelial function and thereby of vascular health. 38 A large body of evidence indicates that hypertensive animals [39] [40] [41] [42] [43] and patients with hypertension 36, 37 are characterized by endothelial dysfunction. NO is rapidly inactivated by O 2 − to form peroxynitrite, exerting nitrosative stress to the cell. 11 In line with a previous report, 44 NO bioavailability was decreased by pathological cyclic stretch that was, in the present study, prevented by p66
Shc silencing, independent of eNOS activation. This finding, together with the above described O 2 − data, supports the idea that the observed decrease in NO levels after pathological stretch is the result of the scavenging action of O 2 − on NO, rather than the result of a changed NO production, and in turn, the increased NO bioavailability on p66
Shc silencing is the result of a decreased O 2 − production. Finally, we studied the regulation of p66 Shc in aortic endothelial cells of SHR, whereby cyclic stretch is known to occur, to test the in vivo relevance of our in vitro data. In these settings, we were able to confirm our in vitro findings by demonstrating increased p66
Shc activation in aortic endothelial cells of SHR compared with WKY rats. Furthermore, as observed in HAECs, we could confirm in aortic homogenates of SHR an increase in O 2 − production and a decrease in NO bioavailability compared with WKY rats underscoring that the pathways elucidated in vitro are also relevant in vivo. These findings are in line with a previous study showing increased activation of p66 Shc in the rat coarctation model of hypertension.
45
Study Limitations
In the present study, we demonstrate an increased activation of p66 Shc in aortic endothelial cells of hypertensive rats, where pathological cyclic stretch occurs. However, there is no clear evidence that this effect is mediated solely by increased cyclic stretch because other factors involved in hypertension, such as shear stress, occur in parallel in the vessels of SHR.
Perspectives
Hypertension is a major risk factor for myocardial infarction and stroke. 1 One in 3 adults is diagnosed with hypertension, 1 thus a clear understanding of the molecular mechanisms underlying hypertension-induced vascular disease is essential for its prevention and treatment. The present study offers new insights into the signaling pathways that may be responsible for mediating the noxious effects of pathological cyclic stretch on endothelial function 36, 37 and demonstrates a crucial role of the adaptor protein p66
Shc in this context. 
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Detailed Material and Methods
Cell Culture Experiments
Primary human aortic endothelial cells (HAECs) (Lonza) were cultured in EBM-2 medium supplied with EGM-2 bullet kit (Lonza). For all experiments, adhering cells were grown to confluence on fibronectin-coated BioFlex ® culture plates (Flexcell International) and rendered quiescent in EBM medium (Lonza) with 0.5% FBS. For all experiments, cells from passages 6 to 9 were used.
To block the MAP kinases p38, extracelluar signal-regulated kinase p44/42 (ERK1/2), or c-Jun N-terminal kinase (JNK1/2), cells were treated with SB203580 (Sigma), PD98059 (Cell Signaling), or SP600125 (Calbiochem) respectively, before pathological stretch exposure. For functional integrin alpha5beta1 (α 5 β 1 ) blocking, cells were pre-incubated with an anti-integrin α 5 β 1 antibody (Millipore), before pathological stretch exposure.
Small Interfering RNA (siRNA) Transfection
Cells were transfected with predesigned siRNA targeting p66 
Application of Cyclic Stretch
Adhering cells on the flexible membrane of BioFlex ® culture plates (Flexcell International) were exposed to different cyclic stretch (0.5 Hz) regimens (2%, 8%, or 15%) with different interval times (1 h, 3 h, 6 h) using the Flexcell ® FX-4000T TM system (Flexcell International). For all ROS, NO, and NADPH oxidase activity measurements as well as mechanistic experiments, a pathological stretch regimen of 15% and 6 h was used. To assess cytotoxicity, a colorimetric assay (Roche) for detection of lactate dehydrogenase (LDH) release was used according to the manufacturer's recommendations. . Separation of proteins was done by SDS-PAGE, followed by the transfer to a polyvinylidene fluoride membrane (Millipore) by semidry transfer. Antibodies against phosphorylated p38, ERK1/2, and JNK1/2 (all from Cell Signaling) were used at 1:1000, 1:5000, and 1:1000 dilution, respectively. Antibodies against p38, ERK1/2, and JNK1/2 protein expression (all from Cell Signaling) were used at 1:2000, 1:5000, and 1:1000 dilution, respectively. Anti-Shc/p66 (pSer36) antibody (Calbiochem) was used at 1:100 dilution. AntipT641PKCβ II (Invitrogen) and anti-Shc (Cell Signaling, or BD Transduction Laboratories TM ) antibodies were used at 1:1000 dilution. Anti-PKCβ II antibody (Santa Cruz) was used at 1:1000 dilution. Antibodies against p-eNOS (Thr495), peNOS (Ser1177), and eNOS (all from BD Transduction Laboratories TM ) were used at 1:5000, 1:2000, and 1:2000 dilution. Immunoblots were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (1:20000 dilution; Millipore) expression. Antirabbit and anti-mouse secondary antibodies were purchased from SouthernBiotech.
Immunoblotting
Measurement of O 2 -Production and NO Bioavailability
O 2 − production was determined using electron spin resonance (ESR) spectroscopy, as previously described -production was measured using following instrumental settings: center field, 3472.0 G; sweep width, 10.00 G; microwave frequency, 9.76 GHz; microwave power, 19.91 mW; modulation frequency, 86.00 kHz; modulation amplitude, 2.60 G; and number of scans, 10. The temperature was set constant at 37° Celsius (temperature-controlled system). Aortic tissue of SHR and WKY rats was incubated with Krebs-HEPES solution (Noxygen) containing 500 μmol/L 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine hydrochloride (Noxygen), 5 μmol/L sodium diethyldithiocarbamate trihydrate (Noxygen), and 25 μmol/L deferoxamine methanesulfonate (Noxygen) for 1 h at 37ºC. Samples frozen in liquid nitrogen were measured on an ESR spectrometer (Bruker) by using following instrumental settings: sweep width, 50.000 G; microwave frequency, 9.78 GHz; microwave power, 19.91 mW; modulation frequency, 86.00 kHz; modulation amplitude, 2.60 G; and number of scans, 10. NO bioavailability was determined using ESR spectroscopy, as previously described 1, 2 . Fe(DETC) 2 was formed by equal volumes of diethyldithiocarbonic acid sodium salt (7.2 mg/10 ml 0.9% NaCl) (Noxygen) and ferrous sulphate heptahydrate (4.5 mg/10 ml 0.9% NaCl) (Noxygen). HAECs, or aortic tissue were incubated with Krebs-HEPES -Fe(DETC) 2 mixture for 1 h at 37ºC and then collected in Krebs-HEPES solution (Noxygen), followed by snap freezing in liquid nitrogen. Frozen samples were measured on an ESR spectrometer (Bruker) using following instrumental HYPE201302129R3 4 settings: center field, 3455.00 G; sweep width, 80.00 G microwave frequency, 9.78 GHz; microwave power, 39.72 mW; modulation frequency, 86.00 kHz; modulation amplitude, 10.34 G; and number of scans, 10.
Animal Experiments
Male spontaneously hypertensive rats (SHR) and male Wistar-Kyoto rats (WKY), all of which 16 weeks old, were purchased from Janvier Labs. Animals had ad libitum access to food (normal chow diet) and water, and were housed under a 12 h light/dark cycle. Following habituation training of the animals, systolic blood pressure (SBP) and heart rate (HR) measurements were performed by tail-cuff method (model LE 5002; Letica). Following anaesthesia by pentobarbital (50 mg/kg i.p.), animals were sacrificed by blood exsanguinations. Aortic tissue was then collected for measurement of O 2 -production and NO bioavailability, and rat aortic endothelial cells were isolated from the aorta for immunoblotting. Study design and experimental protocols were approved by the Cantonal Veterinary Office of the Canton of Zurich. 
Isolation of rat aortic endothelial cells
, pre-treated with 0.1% of gelatine of bovine skin origin (Sigma-Aldrich). Cells were cultured to confluence in growth medium and then lysed for immunoblotting.
